Polarean Imaging CEO Richard Hullihen & Glantus Founder & CEO Maurice Healy

Justin Waite
Vox Markets Podcast with Justin Waite
12:18, 12th May 2021

AudioBoom Player

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here


On today's Vox Markets Podcast: Polarean Imaging CEO Richard Hullihen & Glantus Founder & CEO Maurice Healy

Richard Hullihen, CEO of Polarean Imaging #POLX FOLLOW answers investors questions which range from the FDA approval to potential global roll out.

Polaran Imaging and its wholly owned subsidiary, Polarean, Inc. (together the "Group") are revenue generating, medical drug-device combination companies operating in the high resolution medical imaging market. The Group develops equipment that enables existing MRI systems to achieve an improved level of pulmonary function imaging and specialises in the use of hyperpolarised Xenon gas (129Xe) as an imaging agent to visualise ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream and in the pulmonary vasculature. Xenon gas exhibits solubility and signal properties that enable it to be imaged within other tissues and organs.


Maurice Healy, Founder & CEO of Glantus #GLAN FOLLOW a provider of Accounts Payable automation and analytics solutions talks about their listing yesterday & what they intend to do with the £10m they raised.

Glantus is an ISO 9001, ISO 27001 and ISO 27701 certified provider of Accounts Payable automation and analytics solutions. It utilises a technology that layers onto existing data systems and transforms and analyses data to improve finance automation, and deliver analytics and data science to business users. The Company has developed solutions which focus on three product areas: Active AP Discovery, Intelligent AP Automation and Advanced AP Analytics.

(Interview starts 20 minutes 6 seconds)

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Comments
Login or register to post comments

Recent Articles
Watchlist